Transcriptome studies of CML LSCs and progenitors indicate that the TGFβ and BMP ligands are downregulated in chronic phase (CP)-CML, suggesting an extrinsic mechanism for TGFβ involvement in this disease15. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.